Jun 29, 2008
Alkermes Initiates Phase 3 Clinical Study of VIVITROL(R) for the Treatment of Opioid Dependence
CAMBRIDGE, Mass. - Alkermes, Inc. today announced the initiation of a phase 3 clinical trial of VIVITROL for the treatment of opioid dependence.
Comments
Please note by clicking on "Post Comment" you acknowledge that you have read the Terms of Service and the comment you are posting is in compliance with such terms. Be polite. Inappropriate posts may be removed by the moderator. Send us your feedback.
| Topic | Updated | Last By | Comments |
|---|---|---|---|
| Opportunity walks as Chelsea faces empty Alkerm... (from Apr '08) | Apr '08 | chago | 1 |
| Lilly may drop inhaled insulin venture (from Mar '08) | Mar '08 | Not fooled | 45 |
| Alkermes seeks to market Vivitrol in Europe (from Apr '07) | Apr '07 | Dolores Nunez | 1 |
| Alkermes prices dose of antialcoholism drug (from May '06) | Sep '06 | DIMITRAKIS | 3 |
